<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">25566512</PMID>
      <DateCompleted>
        <Year>2015</Year>
        <Month>07</Month>
        <Day>15</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2018</Year>
        <Month>11</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2235-2988</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>4</Volume>
            <PubDate>
              <Year>2014</Year>
            </PubDate>
          </JournalIssue>
          <Title>Frontiers in cellular and infection microbiology</Title>
          <ISOAbbreviation>Front Cell Infect Microbiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Mechanisms of Borrelia burgdorferi internalization and intracellular innate immune signaling.</ArticleTitle>
        <Pagination>
          <StartPage>175</StartPage>
          <MedlinePgn>175</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">175</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3389/fcimb.2014.00175</ELocationID>
        <Abstract>
          <AbstractText>Lyme disease is a long-term infection whose most severe pathology is characterized by inflammatory arthritis of the lower bearing joints, carditis, and neuropathy. The inflammatory cascades are initiated through the early recognition of invading Borrelia burgdorferi spirochetes by cells of the innate immune response, such as neutrophils and macrophage. B. burgdorferi does not have an intracellular niche and thus much research has focused on immune pathways activated by pathogen recognition molecules at the cell surface, such as the Toll-like receptors (TLRs). However, in recent years, studies have shown that internalization of the bacterium by host cells is an important component of the defense machinery in response to B. burgdorferi. Upon internalization, B. burgdorferi is trafficked through an endo/lysosomal pathway resulting in the activation of a number of intracellular pathogen recognition receptors including TLRs and Nod-like receptors (NLRs). Here we will review the innate immune molecules that participate in both cell surface and intracellular immune activation by B. burgdorferi.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Petnicki-Ocwieja</LastName>
            <ForeName>Tanja</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kern</LastName>
            <ForeName>Aurelie</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2014</Year>
          <Month>12</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Front Cell Infect Microbiol</MedlineTA>
        <NlmUniqueID>101585359</NlmUniqueID>
        <ISSNLinking>2235-2988</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D025065" MajorTopicYN="N">Borrelia burgdorferi</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007113" MajorTopicYN="Y">Immunity, Innate</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008193" MajorTopicYN="N">Lyme Disease</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Borrelia burgdorferi</Keyword>
        <Keyword MajorTopicYN="N">Lyme disease</Keyword>
        <Keyword MajorTopicYN="N">Nod-like receptor signaling</Keyword>
        <Keyword MajorTopicYN="N">Toll-like receptor signaling</Keyword>
        <Keyword MajorTopicYN="N">endosomal signaling</Keyword>
        <Keyword MajorTopicYN="N">phagocytosis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2014</Year>
          <Month>9</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2014</Year>
          <Month>11</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2015</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2015</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2015</Year>
          <Month>7</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">25566512</ArticleId>
        <ArticleId IdType="pmc">PMC4266086</ArticleId>
        <ArticleId IdType="doi">10.3389/fcimb.2014.00175</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Alexopoulou L., Thomas V., Schnare M., Lobet Y., Anguita J., Schoen R. T., et al. . (2002). Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nat. Med. 8, 878–884. 10.1038/nm732</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm732</ArticleId>
            <ArticleId IdType="pubmed">12091878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Behera A. K., Hildebrand E., Uematsu S., Akira S., Coburn J., Hu L. T. (2006). Identification of a TLR-independent pathway for Borrelia burgdorferi-induced expression of matrix metalloproteinases and inflammatory mediators through binding to integrin α3β1. J. Immunol. 177, 657–664
10.4049/jimmunol.177.1.657</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.177.1.657</ArticleId>
            <ArticleId IdType="pubmed">16785564</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berende A., Oosting M., Kullberg B.-J., Netea M. G., Joosten L. A. B. (2010). Activation of innate host defense mechanisms by Borrelia. Eur. Cytokine Netw. 21, 7–18. 10.1684/ecn.2009.0179</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1684/ecn.2009.0179</ArticleId>
            <ArticleId IdType="pubmed">20146985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blasius A. L., Beutler B. (2010). Intracellular toll-like receptors. Immunity
32, 305–315. 10.1016/j.immuni.2010.03.012</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2010.03.012</ArticleId>
            <ArticleId IdType="pubmed">20346772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cervantes J. L., Dunham-Ems S. M., La Vake C. J., Petzke M. M., Sahay B., Sellati T. J., et al. . (2011). Phagosomal signaling by Borrelia burgdorferi in human monocytes involves Toll-like receptor (TLR) 2 and TLR8 cooperativity and TLR8-mediated induction of IFN-beta. Proc. Natl. Acad. Sci. U.S.A. 108, 3683–3688. /-/DCSupplemental 10.1073/pnas.1013776108</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1013776108</ArticleId>
            <ArticleId IdType="pmc">PMC3048123</ArticleId>
            <ArticleId IdType="pubmed">21321205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cervantes J. L., La Vake C. J., Weinerman B., Luu S., O'Connell C., Verardi P. H., et al. . (2013). Human TLR8 is activated upon recognition of Borrelia burgdorferi RNA in the phagosome of human monocytes. J. Leukoc. Biol. 94, 1231–1241. 10.1189/jlb.0413206</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1189/jlb.0413206</ArticleId>
            <ArticleId IdType="pmc">PMC3828603</ArticleId>
            <ArticleId IdType="pubmed">23906644</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chauhan V. S., Sterka D. G., Jr., Furr S. R., Young A. B., Marriott I. (2009). NOD2 plays an important role in the inflammatory responses of microglia and astrocytes to bacterial CNS pathogens. Glia
57, 414–423. 10.1002/glia.20770</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/glia.20770</ArticleId>
            <ArticleId IdType="pmc">PMC2628967</ArticleId>
            <ArticleId IdType="pubmed">18803303</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cinco M., Murgia R., Presani G., Perticarari S. (1997). Integrin CR3 mediates the binding of nonspecifically opsonized Borrelia burgdorferi to human phagocytes and mammalian cells. Infect. Immun. 65, 4784–4789. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC175686</ArticleId>
            <ArticleId IdType="pubmed">9353065</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coburn J., Cugini C. (2003). Targeted mutation of the outer membrane protein P66 disrupts attachment of the Lyme disease agent, Borrelia burgdorferi, to integrin alphavbeta3. Proc. Natl. Acad. Sci. U.S.A. 100, 7301–7306. 10.1073/pnas.1131117100</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1131117100</ArticleId>
            <ArticleId IdType="pmc">PMC165870</ArticleId>
            <ArticleId IdType="pubmed">12748384</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coburn J., Magoun L., Bodary S. C., Leong J. M. (1998). Integrins alpha(v)beta3 and alpha5beta1 mediate attachment of lyme disease spirochetes to human cells. Infect. Immun. 66, 1946–1952. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC108148</ArticleId>
            <ArticleId IdType="pubmed">9573074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Couillin I., Pétrilli V., Martinon F. (2011). The Inflammasomes. Springer: Basel.</Citation>
        </Reference>
        <Reference>
          <Citation>Cruz A. R., Moore M. W., La Vake C. J., Eggers C. H., Salazar J. C., Radolf J. D. (2008). Phagocytosis of Borrelia burgdorferi, the Lyme disease spirochete, potentiates innate immune activation and induces apoptosis in human monocytes. Infect. Immun. 76, 56–70. 10.1128/IAI.01039-07</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.01039-07</ArticleId>
            <ArticleId IdType="pmc">PMC2223637</ArticleId>
            <ArticleId IdType="pubmed">17938216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dietrich N., Lienenklaus S., Weiss S., Gekara N. O. (2010). Murine toll-like receptor 2 activation induces type I interferon responses from endolysosomal compartments. PLoS ONE
5:e10250. 10.1371/journal.pone.0010250.s004</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0010250.s004</ArticleId>
            <ArticleId IdType="pmc">PMC2857745</ArticleId>
            <ArticleId IdType="pubmed">20422028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention  (2013). Press Release: CDC Provides Estimate of Americans Diagnosed with Lyme Disease Each Year. cdc.gov. Available at: http://www.cdc.gov/media/releases/2013/p0819-lyme-disease.html [Accessed November 17, 2014].</Citation>
        </Reference>
        <Reference>
          <Citation>Dixit E., Boulant S., Zhang Y., Lee A. S. Y., Odendall C., Shum B., et al. . (2010). Peroxisomes are signaling platforms for antiviral innate immunity. Cell
141, 668–681. 10.1016/j.cell.2010.04.018</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2010.04.018</ArticleId>
            <ArticleId IdType="pmc">PMC3670185</ArticleId>
            <ArticleId IdType="pubmed">20451243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eisenbarth S. C., Flavell R. A. (2009). Innate instruction of adaptive immunity revisited: the inflammasome. EMBO Mol. Med. 1, 92–98. 10.1002/emmm.200900014</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/emmm.200900014</ArticleId>
            <ArticleId IdType="pmc">PMC3378119</ArticleId>
            <ArticleId IdType="pubmed">20049709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Franchi L., Muñoz-Planillo R., Reimer T., Eigenbrod T., Núñez G. (2010). Inflammasomes as microbial sensors. Eur. J. Immunol. 40, 611–615. 10.1002/eji.200940180</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/eji.200940180</ArticleId>
            <ArticleId IdType="pubmed">20201013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gandotra S., Jang S., Murray P. J., Salgame P., Ehrt S. (2007). Nucleotide-binding oligomerization domain protein 2-deficient mice control infection with Mycobacterium tuberculosis. Infect. Immun. 75, 5127–5134. 10.1128/IAI.00458-07</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00458-07</ArticleId>
            <ArticleId IdType="pmc">PMC2168277</ArticleId>
            <ArticleId IdType="pubmed">17709422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gerold G., Ajaj K. A., Bienert M., Laws H.-J., Zychlinsky A., de Diego J. L. (2008). A Toll-like receptor 2–integrin β 3 complex senses bacterial lipopeptides via vitronectin. Nat. Immunol. 9, 761–768. 10.1038/ni.1618</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ni.1618</ArticleId>
            <ArticleId IdType="pubmed">18516040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hastey C. J., Ochoa J., Olsen K. J., Barthold S. W., Baumgarth N. (2014). MyD88- and TRIF-independent induction of type I interferon drives naive B cell accumulation but not loss of lymph node architecture in Lyme disease. Infect. Immun. 82, 1548–1558. 10.1128/IAI.00969-13</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00969-13</ArticleId>
            <ArticleId IdType="pmc">PMC3993384</ArticleId>
            <ArticleId IdType="pubmed">24452685</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hawley K. L., Martín-Ruiz I., Iglesias-Pedraz J. M., Berwin B., Anguita J. (2013). CD14 targets complement receptor 3 to lipid rafts during phagocytosis of Borrelia burgdorferi. Int. J. Biol. Sci. 9, 803–810. 10.7150/ijbs.7136</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7150/ijbs.7136</ArticleId>
            <ArticleId IdType="pmc">PMC3753444</ArticleId>
            <ArticleId IdType="pubmed">23983613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hawley K. L., Olson C. M., Iglesias-Pedraz J. M., Navasa N., Cervantes J. L., Caimano M. J., et al. . (2012). CD14 cooperates with complement receptor 3 to mediate MyD88-independent phagocytosis of Borrelia burgdorferi. Proc. Natl. Acad. Sci. U.S.A. 109, 1228–1232. /-/DCSupplemental 10.1073/pnas.1112078109</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1112078109</ArticleId>
            <ArticleId IdType="pmc">PMC3268315</ArticleId>
            <ArticleId IdType="pubmed">22232682</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hedl M., Li J., Cho J. H., Abraham C. (2007). Chronic stimulation of Nod2 mediates tolerance to bacterial products. Proc. Natl. Acad. Sci. U.S.A. 104, 19440–19445. 10.1073/pnas.0706097104</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0706097104</ArticleId>
            <ArticleId IdType="pmc">PMC2148308</ArticleId>
            <ArticleId IdType="pubmed">18032608</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hirschfeld M., Kirschning C. J., Schwandner R., Wesche H., Weis J. H., Wooten R. M., et al. . (1999). Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J. Immunol. 163, 2382–2386. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10452971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hugot J. P., Chamaillard M., Zouali H., Lesage S., Cézard J. P., Belaiche J., et al. . (2001). Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature
411, 599–603. 10.1038/35079107</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/35079107</ArticleId>
            <ArticleId IdType="pubmed">11385576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kagan J. C. (2012). Perspective. Cell
151, 1168–1178
10.1016/j.cell.2012.11.011</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2012.11.011</ArticleId>
            <ArticleId IdType="pmc">PMC3523748</ArticleId>
            <ArticleId IdType="pubmed">23217704</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kagan J. C., Medzhitov R. (2006). Phosphoinositide-mediated adaptor recruitment controls toll-like receptor signaling. Cell
125, 943–955. 10.1016/j.cell.2006.03.047</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2006.03.047</ArticleId>
            <ArticleId IdType="pubmed">16751103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kanneganti T.-D., Lamkanfi M., Núñez G. (2007). Intracellular NOD-like receptors in host defense and disease. Immunity
27, 549–559. 10.1016/j.immuni.2007.10.002</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2007.10.002</ArticleId>
            <ArticleId IdType="pubmed">17967410</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Katze M. G., He Y., Gale M. (2002). Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2, 675–687. 10.1038/nri888</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nri888</ArticleId>
            <ArticleId IdType="pubmed">12209136</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kawai T., Akira S. (2011). Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity
34, 637–650. 10.1016/j.immuni.2011.05.006</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2011.05.006</ArticleId>
            <ArticleId IdType="pubmed">21616434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kayagaki N., Warming S., Lamkanfi M., Walle L. V., Louie S., Dong J., et al. . (2012). Non-canonical inflammasome activation targets caspase-11. Nature
479, 117–121. 10.1038/nature10558</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature10558</ArticleId>
            <ArticleId IdType="pubmed">22002608</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lien E. (1999). Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274, 33419–33425. 10.1074/jbc.274.47.33419</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.274.47.33419</ArticleId>
            <ArticleId IdType="pubmed">10559223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Linder S., Heimerl C., Fingerle V., Aepfelbacher M., Wilske B. (2001). Coiling phagocytosis of Borrelia burgdorferi by primary human macrophages is controlled by CDC42Hs and Rac1 and involves recruitment of Wiskott-Aldrich syndrome protein and Arp2/3 complex. Infect. Immun. 69, 1739–1746. 10.1128/IAI.69.3.1739-1746.2001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.69.3.1739-1746.2001</ArticleId>
            <ArticleId IdType="pmc">PMC98080</ArticleId>
            <ArticleId IdType="pubmed">11179351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lindgren E., Jaenson T. G. T., World Health Organization, Regional Office for Europe  (2006). Lyme Borreliosis in Europe. Copenhagen: WHO Regional Office for Europe.</Citation>
        </Reference>
        <Reference>
          <Citation>Liu N., Belperron A. A., Booth C. J., Bockenstedt L. K. (2009). The caspase 1 inflammasome is not required for control of murine Lyme borreliosis. Infect. Immun. 77, 3320–3327
10.1128/IAI.00100-09</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00100-09</ArticleId>
            <ArticleId IdType="pmc">PMC2715671</ArticleId>
            <ArticleId IdType="pubmed">19487481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marre M. L., Petnicki-Ocwieja T., DeFrancesco A. S., Darcy C. T., Hu L. T. (2010). Human integrin α(3)β (1) regulates TLR2 recognition of lipopeptides from endosomal compartments. PLoS ONE
5:e12871. 10.1371/journal.pone.0012871.g012</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0012871.g012</ArticleId>
            <ArticleId IdType="pmc">PMC2943923</ArticleId>
            <ArticleId IdType="pubmed">20877569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martinon F., Burns K., Tschopp J. (2002). The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell
10, 417–426. 10.1016/S1097-2765(02)00599-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1097-2765(02)00599-3</ArticleId>
            <ArticleId IdType="pubmed">12191486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miller J. C., Ma Y., Bian J., Sheehan K. C. F., Zachary J. F., Weis J. H., et al. . (2008). A critical role for type I IFN in arthritis development following Borrelia burgdorferi infection of mice. J. Immunol. 181, 8492–8503. 10.4049/jimmunol.181.12.8492</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.181.12.8492</ArticleId>
            <ArticleId IdType="pmc">PMC3024833</ArticleId>
            <ArticleId IdType="pubmed">19050267</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miller J. C., Maylor-Hagen H., Ma Y., Weis J. H., Weis J. J. (2010). The Lyme disease spirochete Borrelia burgdorferi utilizes multiple ligands, including RNA, for interferon regulatory factor 3-dependent induction of type I interferon-responsive genes. Infect. Immun. 78, 3144–3153. 10.1128/IAI.01070-09</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.01070-09</ArticleId>
            <ArticleId IdType="pmc">PMC2897372</ArticleId>
            <ArticleId IdType="pubmed">20404081</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moore M. W., Cruz A. R., LaVake C. J., Marzo A. L., Eggers C. H., Salazar J. C., et al. . (2007). Phagocytosis of Borrelia burgdorferi and Treponema pallidum potentiates innate immune activation and induces gamma interferon production. Infect. Immun. 75, 2046–2062. 10.1128/IAI.01666-06</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.01666-06</ArticleId>
            <ArticleId IdType="pmc">PMC1865718</ArticleId>
            <ArticleId IdType="pubmed">17220323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moreira L. O., Zamboni D. S. (2012). NOD1 and NOD2 signaling in infection and inflammation. Front. Immunol. 3:328. 10.3389/fimmu.2012.00328</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2012.00328</ArticleId>
            <ArticleId IdType="pmc">PMC3492658</ArticleId>
            <ArticleId IdType="pubmed">23162548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Müllegger R. R., McHugh G., Ruthazer R., Binder B., Kerl H., Steere A. C. (2000). Differential expression of cytokine mRNA in skin specimens from patients with erythema migrans or acrodermatitis chronica atrophicans. J. Invest. Dermatol. 115, 1115–1123. 10.1046/j.1523-1747.2000.00198.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1523-1747.2000.00198.x</ArticleId>
            <ArticleId IdType="pubmed">11121150</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Netea M. G., Kullberg B.-J., de Jong D. J., Franke B., Sprong T., Naber T. H. J., et al. . (2004). NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease. Eur. J. Immunol. 34, 2052–2059. 10.1002/eji.200425229</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/eji.200425229</ArticleId>
            <ArticleId IdType="pubmed">15214053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oosting M., Berende A., Sturm P., Ter Hofstede H. J. M., de Jong D. J., Kanneganti T.-D., et al. . (2010a). Recognition of Borrelia burgdorferi by NOD2 is central for the induction of an inflammatory reaction. J. Infect. Dis. 201, 1849–1858. 10.1086/652871</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/652871</ArticleId>
            <ArticleId IdType="pubmed">20441518</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oosting M., Buffen K., Malireddi S. R., Sturm P., Verschueren I., Koenders M. I., et al. . (2012). Murine Borrelia arthritis is highly dependent on ASC and caspase-1, but independent of NLRP3. Arthritis Res. Ther. 14, R247. 10.1186/ar4090</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/ar4090</ArticleId>
            <ArticleId IdType="pmc">PMC3674595</ArticleId>
            <ArticleId IdType="pubmed">23148704</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oosting M., van de Veerdonk F. L., Kanneganti T.-D., Sturm P., Verschueren I., Berende A., et al. . (2010b). Borrelia species induce inflammasome activation and IL-17 production through a caspase-1-dependent mechanism. Eur. J. Immunol. 41, 172–181. 10.1002/eji.201040385</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/eji.201040385</ArticleId>
            <ArticleId IdType="pmc">PMC3939779</ArticleId>
            <ArticleId IdType="pubmed">21182088</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perry A. K., Chen G., Zheng D., Tang H., Cheng G. (2005). The host type I interferon response to viral and bacterial infections. Cell Res. 15, 407–422. 10.1038/sj.cr.7290309</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.cr.7290309</ArticleId>
            <ArticleId IdType="pubmed">15987599</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petnicki-Ocwieja T., Chung E., Acosta D. I., Ramos L. T., Shin O. S., Ghosh S., et al. . (2013). TRIF mediates toll-like receptor 2-dependent inflammatory responses to Borrelia burgdorferi. Infect. Immun. 81, 402–410. 10.1128/IAI.00890-12</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00890-12</ArticleId>
            <ArticleId IdType="pmc">PMC3553797</ArticleId>
            <ArticleId IdType="pubmed">23166161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petnicki-Ocwieja T., DeFrancesco A. S., Chung E., Darcy C. T., Bronson R. T., Kobayashi K. S., et al. . (2011). Nod2 suppresses Borrelia burgdorferi mediated murine Lyme arthritis and carditis through the induction of tolerance. PLoS ONE
6:e17414. 10.1371/journal.pone.0017414.t001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0017414.t001</ArticleId>
            <ArticleId IdType="pmc">PMC3046161</ArticleId>
            <ArticleId IdType="pubmed">21387014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petzke M. M., Brooks A., Krupna M. A., Mordue D., Schwartz I. (2009). Recognition of Borrelia burgdorferi, the Lyme disease spirochete, by TLR7 and TLR9 induces a type I IFN response by human immune cells. J. Immunol. 183, 5279–5292. 10.4049/jimmunol.0901390</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.0901390</ArticleId>
            <ArticleId IdType="pubmed">19794067</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pietruczuk A., Świerzbińska R., Pancewicz S., Pietruczuk M., Hermanowska-Szpakowicz T. (2006). Serum levels of Interleukin-18 (IL-18), Interleukin-1β (IL-1β), its soluble receptor sIL-1RII and C-reactive protein (CRP) in patients with lyme arthritis. Infection
34, 158–162. 10.1007/s15010-006-5013-z</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s15010-006-5013-z</ArticleId>
            <ArticleId IdType="pubmed">16804660</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rittig M. G., Krause A., Häupl T., Schaible U. E., Modolell M., Kramer M. D., et al. . (1992). Coiling phagocytosis is the preferential phagocytic mechanism for Borrelia burgdorferi. Infect. Immun. 60, 4205–4212. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC257454</ArticleId>
            <ArticleId IdType="pubmed">1398932</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salazar J. C., Duhnam-Ems S., La Vake C., Cruz A. R., Moore M. W., Caimano M. J., et al. . (2009). Activation of human monocytes by live Borrelia burgdorferi generates TLR2-dependent and -independent responses which include induction of IFN-beta. PLoS Pathog. 5:e1000444. 10.1371/journal.ppat.1000444</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.1000444</ArticleId>
            <ArticleId IdType="pmc">PMC2679197</ArticleId>
            <ArticleId IdType="pubmed">19461888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shamsul H. M., Hasebe A., Iyori M., Ohtani M., Kiura K., Zhang D., et al. . (2010). The Toll-like receptor 2 (TLR2) ligand FSL-1 is internalized via the clathrin-dependent endocytic pathway triggered by CD14 and CD36 but not by TLR2. Immunology
130, 262–272. 10.1111/j.1365-2567.2009.03232.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2567.2009.03232.x</ArticleId>
            <ArticleId IdType="pmc">PMC2878470</ArticleId>
            <ArticleId IdType="pubmed">20113368</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shin O. S., Isberg R. R., Akira S., Uematsu S., Behera A. K., Hu L. T. (2008). Distinct roles for MyD88 and Toll-like receptors 2, 5, and 9 in phagocytosis of Borrelia burgdorferi and cytokine induction. Infect. Immun. 76, 2341–2351. 10.1128/IAI.01600-07</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.01600-07</ArticleId>
            <ArticleId IdType="pmc">PMC2423091</ArticleId>
            <ArticleId IdType="pubmed">18378636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shin O. S., Miller L. S., Modlin R. L., Akira S., Uematsu S., Hu L. T. (2009). Downstream signals for MyD88-mediated phagocytosis of Borrelia burgdorferi can be initiated by TRIF and are dependent on PI3K. J. Immunol. 183, 491–498. 10.4049/jimmunol.0900724</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.0900724</ArticleId>
            <ArticleId IdType="pmc">PMC2772066</ArticleId>
            <ArticleId IdType="pubmed">19542460</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steere A. C. (2001). Lyme disease. N. Engl. J. Med. 345, 115–125. 10.1056/NEJM200107123450207</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM200107123450207</ArticleId>
            <ArticleId IdType="pubmed">11450660</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sterka D., Jr., Marriott I. (2006). Characterization of nucleotide-binding oligomerization domain (NOD) protein expression in primary murine microglia. J. Neuroimmunol. 179, 65–75. 10.1016/j.jneuroim.2006.06.009</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2006.06.009</ArticleId>
            <ArticleId IdType="pubmed">16842862</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strober W., Murray P. J., Kitani A., Watanabe T. (2005). Signalling pathways and molecular interactions of NOD1 and NOD2. Nat. Rev. Immunol. 6, 9–20. 10.1038/nri1747</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nri1747</ArticleId>
            <ArticleId IdType="pubmed">16493424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strowig T., Henao-Mejia J., Elinav E., Flavell R. (2012). Inflammasomes in health and disease. Nature
481, 278–286. 10.1038/nature10759</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature10759</ArticleId>
            <ArticleId IdType="pubmed">22258606</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takayama K., Rothenberg R. J., Barbour A. G. (1987). Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi. Infect. Immun. 55, 2311–2313. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC260699</ArticleId>
            <ArticleId IdType="pubmed">3623705</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takeda K., Akira S. (2004). TLR signaling pathways. Semin. Immunol. 16, 3–9. 10.1016/j.smim.2003.10.003</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.smim.2003.10.003</ArticleId>
            <ArticleId IdType="pubmed">14751757</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takeuchi O., Akira S. (2010). Pattern recognition receptors and inflammation. Cell
140, 805–820. 10.1016/j.cell.2010.01.022</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2010.01.022</ArticleId>
            <ArticleId IdType="pubmed">20303872</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilmanski J. M., Petnicki-Ocwieja T., Kobayashi K. S. (2007). NLR proteins: integral members of innate immunity and mediators of inflammatory diseases. J. Leukoc. Biol. 83, 13–30. 10.1189/jlb.0607402</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1189/jlb.0607402</ArticleId>
            <ArticleId IdType="pmc">PMC3256237</ArticleId>
            <ArticleId IdType="pubmed">17875812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wormser G. P., Dattwyler R. J., Shapiro E. D., Halperin J. J., Steere A. C., Klempner M. S., et al. . (2006). The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis. 43, 1089–1134. 10.1086/508667</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/508667</ArticleId>
            <ArticleId IdType="pubmed">17029130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu J., Weening E. H., Faske J. B., Höök M., Skare J. T. (2011). Invasion of eukaryotic cells by Borrelia burgdorferi requires β (1) integrins and Src kinase activity. Infect. Immun. 79, 1338–1348. 10.1128/IAI.01188-10</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.01188-10</ArticleId>
            <ArticleId IdType="pmc">PMC3067508</ArticleId>
            <ArticleId IdType="pubmed">21173306</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamamoto M., Sato S., Hemmi H., Sanjo H., Uematsu S., Kaisho T., et al. . (2002). Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature
420, 324–329. 10.1038/nature01182</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature01182</ArticleId>
            <ArticleId IdType="pubmed">12447441</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
